Skip to main content
. Author manuscript; available in PMC: 2020 Jan 3.
Published in final edited form as: Nat Med. 2019 Jul 3;25(7):1057–1063. doi: 10.1038/s41591-019-0498-z

Extended Data Figure 4 |. Immunotherapeutic bacteria limit tumor growth in syngeneic murine models of melanoma and triple negative breast cancer.

Extended Data Figure 4 |

a, Relative body weight of B16-F10 bearing C57BL/6 mice over time (n=4–5 mice per group, ns, two-way ANOVA with Tukey’s multiple comparisons test) b, Individual tumor growth trajectories of subcutaneous 4T1 tumors following intratumoral eSLC or eSLC-CD47nb injection (n=6–8 per group). c, Individual tumor growth trajectories of subcutaneous B16-F10 melanoma following intraperitoneal miap301 or intratumoral PBS, eSLC, or eSLC-CD47nb injection (n=8–12 per group).